Qfitlia
- Product NDC
- 58468-0348
- 11-digit product format
- 584680348
- Labeler code
- 58468
- Product ID
- 58468-0348_1c225007-61f2-4c48-a25e-f08b8d356a59
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fitusiran
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Genzyme Corporation
- Application
- NDA219019
- Marketing category
- NDA
- Marketing start
- 2025-03-28
- Substance
- FITUSIRAN
- Active strength
- 50 mg/.5mL
- Pharmacologic classes
- Antithrombin-directed RNA Interaction [EPC], Decreased RNA Integrity [PE], Increased RNA Degradation [PE], RNA, Small Interfering [CS], Small Interfering RNA [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Qfitlia
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FITUSIRAN | 50 mg/.5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SV9W47ZLE1 |
| Rxcui | 2709452, 2709458, 2709461, 2709464 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 58468-0348-1 | Qfitlia | 0.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.5 | | 6 |
| 58468-0348-1 | Qfitlia | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 58468-0348 | QFITLIA (FITUSIRAN) INJECTION, SOLUTION [GENZYME CORPORATION] | 3 | Current NDC, 2 package rows | 20250331_6dd2f8ac-6f90-4cbf-b197-97d74964135c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 58468-0348-1 | 58468034801 | 1 SYRINGE in 1 CARTON (58468-0348-1) / .5 mL in 1 SYRINGE | 1 syringe | 2025-03-28 | No | No | Current |